-
Innovation Ranking
Innovation Ranking – RBC Bearings Inc
RBC Bearings Inc (RBC) is a manufacturing company that designs, manufactures and markets bearing products. The company offered industrial and aerospace bearing. Its industrial product portfolio includes ball bearings, cam followers, collets and toolholders, pins, rollers, shafts, rod ends, heavy duty needle roller bearings, self-lubricating bearings, slewing ring bearings and spherical plain bearings, among others. RBC Bearings aerospace products comprise airframe control ball bearings, ball bearing rod ends, airframe control needle track rollers, stud type track roller bearings, and others....
-
Innovation Ranking
Innovation Ranking – Luoyang Bearing Science & Technology Co., Ltd.
Sinomach Precision Industry Co Ltd (Sinomach Precision) is a manufacturer and supplier of bearing and abrasive products. The company offers products including petroleum machinery bearings, precision bearings, slewing bearings, wind turbine bearings, bearings for rolling mills and special precision bearings. Sinomach Precision also provides coated abrasives, ordinary abrasives, superhard material products, consolidated abrasives, testing equipment and industry-specific equipment. The company offers its products to the aerospace, shipping, machine tools, wind power, mining and metallurgy and petrochemical industries. In addition, the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PRO-1184 in Fallopian Tube Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PRO-1184 in Fallopian Tube Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PRO-1184 in Fallopian Tube Cancer Drug Details: PRO-1184 is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PRO-1184 in Peritoneal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PRO-1184 in Peritoneal Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PRO-1184 in Peritoneal Cancer Drug Details: PRO-1184 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PRO-1184 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PRO-1184 in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PRO-1184 in Solid Tumor Drug Details: PRO-1184 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PRO-1184 in Endometrial Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PRO-1184 in Endometrial Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PRO-1184 in Endometrial Cancer Drug Details: PRO-1184 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PRO-1184 in Non-Small Cell Lung Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PRO-1184 in Non-Small Cell Lung Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PRO-1184 in Non-Small Cell Lung Cancer Drug Details: PRO-1184...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PRO-1184 in Malignant Mesothelioma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PRO-1184 in Malignant Mesothelioma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PRO-1184 in Malignant Mesothelioma Drug Details: PRO-1184 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PRO-1184 in Triple-Negative Breast Cancer (TNBC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PRO-1184 in Triple-Negative Breast Cancer (TNBC) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PRO-1184 in Triple-Negative Breast Cancer (TNBC) Drug Details: PRO-1184...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – PRO-1184 in Epithelial Ovarian Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - PRO-1184 in Epithelial Ovarian Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. PRO-1184 in Epithelial Ovarian Cancer Drug Details: PRO-1184 is under...